Literature DB >> 26522929

Opioid metabolism and clinical aspects.

Sebastiano Mercadante1.   

Abstract

Opioids are are commonly used for the management of acute and chronic pain. Opioids have different physicochemical and pharmacokinetic characteristics, which explain the profound changes in the clinical effect in several clinical conditions. Pharmacokinetics influences the opioid response affecting bioavailability, production of metabolites with residual clinical activity, and elimination. Generality of opioid metabolism and clinical implications for specific opioids in different clinical conditions were reviewed to bridge the gap between pharmacokinetics and clinical response. The knowledge of opioid metabolism is essential, particularly for older and complicated patients who receive multiple medications and may have impaired of renal and hepatic function. The recognition of possible metabolic problems and the consideration of adverse drug-drug interactions are fundamental to optimize the use of opioids in clinical practice.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genetics; Metabolism; Opioids; Pain; Polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26522929     DOI: 10.1016/j.ejphar.2015.10.049

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  Options for Treating Pain in Cancer Patients with Dysphagia.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 2.  Cancer Pain Treatment Strategies in Patients with Cancer.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2022-09-21       Impact factor: 11.431

Review 3.  [Differential indications of opioids in pain therapy].

Authors:  J Heyn; S C Azad
Journal:  Anaesthesist       Date:  2017-11       Impact factor: 1.041

Review 4.  Pancreas Cancer-Associated Pain Management.

Authors:  Andrew L Coveler; Jonathan Mizrahi; Bory Eastman; Smith Jim Apisarnthanarax; Shalini Dalal; Terry McNearney; Shubham Pant
Journal:  Oncologist       Date:  2021-05-12

5.  SEOM clinical guideline for treatment of cancer pain (2017).

Authors:  C Jara; S Del Barco; C Grávalos; S Hoyos; B Hernández; M Muñoz; T Quintanar; J A Meana; C Rodriguez; R de Las Peñas
Journal:  Clin Transl Oncol       Date:  2017-11-10       Impact factor: 3.405

6.  Chinese herb cinobufagin-reduced cancer pain is associated with increased peripheral opioids by invaded CD3/4/8 lymphocytes.

Authors:  Tao Chen; Shenjun Yuan; Xin-Nian Wan; Ling Zhan; Xue-Qin Yu; Jian-Hong Zeng; Hong Li; Wen Zhang; Xiang-Yang Hu; Yi-Fei Ye; Wei Hu
Journal:  Oncotarget       Date:  2017-02-14

7.  Influence of training and competitive sessions on peripheral β-endorphin levels in training show jumping horses.

Authors:  Cristina Cravana; P Medica; G Ragonese; E Fazio
Journal:  Vet World       Date:  2017-01-18

Review 8.  Cancer Pain Management: Opioid Analgesics, Part 2.

Authors:  Rita J Wickham
Journal:  J Adv Pract Oncol       Date:  2017-09-01

Review 9.  Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management.

Authors:  Xiu-Qin Feng; Ling-Ling Zhu; Quan Zhou
Journal:  J Pain Res       Date:  2017-05-24       Impact factor: 3.133

10.  Efficacy of nebulized fentanyl and low dose ketamine for pain control of patients with long bone fractures: A randomized, double-blind, clinical trial.

Authors:  Mohammadreza Maleki Verki; Javad Mozafari; Fateme Tirandaz; Hassan Motamed; Afsane Khazaeli
Journal:  Afr J Emerg Med       Date:  2019-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.